We are live on ! Find out more
CMBA

C.M. Bidwell & Associates Portfolio holdings

AUM $214M
1-Year Est. Return 18.82%
This Fund
S&P 500
This Quarter Est. Return
+6.49%
1 Year Est. Return
+18.82%
3 Year Est. Return
+59.8%
5 Year Est. Return
+72.92%
10 Year Est. Return
+638.85%
AUM
$439M
AUM Growth
+$22.7M
Cap. Flow
+$1.23M
Cap. Flow %
0.28%
Top 10 Hldgs %
18.86%
Holding
332
New
121
Increased
28
Reduced
53
Closed
100

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$7.29M
2
AXP icon
American Express
AXP
+$7.22M
3
CVS icon
CVS Health
CVS
+$4.98M
4
DVN icon
Devon Energy
DVN
+$4.92M
5
AMP icon
Ameriprise Financial
AMP
+$4.87M

Top Sells

Rank Stock Value
1
SCHW
Charles Schwab
SCHW
+$8.18M
2
CB icon
Chubb
CB
+$7.62M
3
NSC icon
Norfolk Southern
NSC
+$7.16M
4
PSA icon
Public Storage
PSA
+$7.08M
5
CPB icon
Campbell Soup
CPB
+$6.99M

Sector Composition

Rank Sector Weight
1 Technology 16.64%
2 Financials 14.44%
3 Healthcare 13.99%
4 Industrials 11.57%
5 Energy 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRK icon
101
Comstock Resources
CRK
$3.94B
$361K 0.08%
2,500
-2,448
-49% -$322K
MGA icon
102
Magna International
MGA
$18.8B
$357K 0.08%
+6,620
New +$337K
WELL icon
103
Welltower
WELL
$171B
$356K 0.08%
+5,675
New +$357K
BRCM
104
DELISTED
BROADCOM CORP CL-A
BRCM
$354K 0.08%
9,550
– –
LM
105
DELISTED
Legg Mason, Inc.
LM
$346K 0.08%
+6,740
New +$325K
CSC
106
DELISTED
Computer Sciences
CSC
$341K 0.08%
12,790
-127,680
-91% -$3.3M
AAPL icon
107
Apple
AAPL
$4.57T
$331K 0.08%
+14,252
New +$303K
MYGN icon
108
Myriad Genetics
MYGN
$312M
$328K 0.07%
8,425
– –
MJN
109
DELISTED
Mead Johnson Nutrition Company
MJN
$327K 0.07%
+3,505
New +$306K
SJM icon
110
J.M. Smucker
SJM
$12.8B
$324K 0.07%
+3,040
New +$305K
ACGL icon
111
Arch Capital
ACGL
$33.6B
$323K 0.07%
+16,875
New +$321K
M icon
112
Macy's
M
$6.68B
$323K 0.07%
+5,570
New +$323K
HSP
113
DELISTED
HOSPIRA INC
HSP
$323K 0.07%
+6,285
New +$298K
TEVA icon
114
Teva Pharmaceuticals
TEVA
$41.2B
$321K 0.07%
+6,125
New +$313K
WU icon
115
Western Union
WU
$2.21B
$318K 0.07%
+18,365
New +$297K
ALK icon
116
Alaska Air
ALK
$5.58B
$304K 0.07%
6,400
-430
-6% -$20.5K
CMA
117
DELISTED
Comerica
CMA
$303K 0.07%
6,040
– –
GATX icon
118
GATX Corp
GATX
$6.27B
$297K 0.07%
4,435
+3,445
+348% +$225K
BMY icon
119
Bristol-Myers Squibb
BMY
$132B
$286K 0.07%
5,905
– –
EMN icon
120
Eastman Chemical
EMN
$8.42B
$273K 0.06%
3,130
– –
G icon
121
Genpact
G
$5.81B
$271K 0.06%
+15,485
New +$265K
ITGR icon
122
Integer Holdings
ITGR
$4.26B
$270K 0.06%
6,044
– –
CAAS icon
123
China Automotive Systems
CAAS
$133M
$263K 0.06%
+30,270
New +$251K
DOV icon
124
Dover
DOV
$28.4B
$262K 0.06%
3,572
-60,748
-94% -$4.25M
FE icon
125
FirstEnergy
FE
$27.5B
$262K 0.06%
7,540
– –
3 4
5
6 7

Similar funds

TSS
Taylor Securities Services Harrisburg, Pennsylvania $214M AUM
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return
IH
IES Holdings Houston, Texas $214M AUM
SIA
Serenity Investment Advisors Chicago, Illinois $214M AUM
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
VEA
Virtus ETF Advisers New York $215M AUM 53.68% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $215M AUM

C.M. Bidwell & Associates's Q2 2014 Portfolio in Review

As of Q2 2014, C.M. Bidwell & Associates held 332 positions worth $439M, up 5.5% from $416M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

C.M. Bidwell & Associates's Q2 2014 filing shows 121 new, 28 increased, 53 reduced and 100 closed positions. Its largest new stake was Gilead Sciences: 93,610 shares worth $7.76M. The largest sale was Charles Schwab, an estimated $8.18M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • C.M. Bidwell & Associates's largest Q2 2014 buy was Gilead Sciences: 93,610 shares worth $7.76M.
  • C.M. Bidwell & Associates added most to CVS Health in Q2 2014, an estimated $4.98M increase.
  • C.M. Bidwell & Associates's biggest Q2 2014 reduction was Chubb, cutting an estimated $7.62M.
  • C.M. Bidwell & Associates fully exited Charles Schwab in Q2 2014, selling an estimated $8.18M.
  • C.M. Bidwell & Associates's ten largest holdings make up 19% of its $439M portfolio in Q2 2014.
  • C.M. Bidwell & Associates opened 121 new positions and closed 100 in Q2 2014.
  • C.M. Bidwell & Associates's portfolio value rose 5.5% quarter-over-quarter to $439M.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2014, filed 12 Aug 2014.